BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| KU-60019 | KU-60019 is a potent and selective ATM inhibitor. KU-60019 is 10-fold more effective than KU-55933 at blocking radiation-induced phosphorylation of key ATM targets in human glioma cells. As expected, KU-60019 is a highly effective radiosensitizer of human glioma cells. KU-60019 inhibits the DNA damage response, reduces AKT phosphorylation and prosurvival signaling, inhibits migration and invasion, and effectively radiosensitizes human glioma cells. Group: Pharmaceutical. CAS No. 925701-49-1. Pack Sizes: 25 mg. Product ID: B2693-286438. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Kukoamine A | Kukoamine A is a spermine alkaloid isolated from Lycium chinense, potatoes, and tomatoes. It exhibits diverse biological activities, including anticancer, neuroprotective, and anti-inflammatory properties. Kukoamine A inhibits human glioblastoma cell growth and migration via apoptosis induction and epithelial-mesenchymal transition attenuation mediated by downregulating expressions of 5-LOX and C/EBP&beta. Group: Pharmaceutical. CAS No. 75288-96-9. Pack Sizes: 10 mg. Product ID: B1370-209430. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Kuromanin chloride | Kuromanin chloride is a natural compound found in Amelanchier spicata, Acer paxii. It is a scavenger of peroxynitrite that exerts a protective effect against endothelial dysfunction and vascular failure induced by peroxynitrite. Uses: Antioxidative. Group: Pharmaceutical. CAS No. 7084-24-4. Pack Sizes: 25 mg. Product ID: B2703-001263. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Kushenol A | Kushenol A isolated from the roots of Sophora flavescens Ait. It shows selective alpha-glucosidase inhibitory activity. Group: Pharmaceutical. CAS No. 99217-63-7. Pack Sizes: 5 mg. Product ID: NP2470. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Kushenol I | Kushenol I is a compound of the flavonoid class found in the Sophora flavescens Ait. Kushenol I is a GABAA receptor modulator and a Sodium-dependent glucose cotransporter 2(SGLT2) inhibitor. Group: Pharmaceutical. CAS No. 99119-69-4. Pack Sizes: 5 mg. Product ID: B0005-053514. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Kushenol X | Kushenol X isolated from the roots of Sophora flavescens Ait. Uses: Antibacterial; antiandrogen. Group: Pharmaceutical. CAS No. 254886-77-6. Pack Sizes: 1 mg. Product ID: NP2380. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Kuwanon E | Kuwanon E is a flavonoid compound found in the root bark of Morus alba L. Group: Pharmaceutical. CAS No. 68401-05-8. Pack Sizes: 5 mg. Product ID: NP2502. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| KW-2449 | KW-2449 is a novel multikinase inhibitor, which suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation. Recent research showed that HDACIs increase KW-2449 lethality in Bcr/Abl(+) cells in association with inhibition of Bcr/Abl, generation of ROS, and induction of DNA damage. This strategy preferentially targets primary Bcr/Abl(+) hematopoietic cells and exhibits enhanced in vivo activity. Combining KW-2449 with HDACIs warrants attention in IM-resistant Bcr/Abl(+) leukemias. Group: Pharmaceutical. CAS No. 1000669-72-6. Pack Sizes: 100 mg. Product ID: B0084-286439. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| KX2-391 | KX2-391 is an orally bioavailable small molecule Src kinase inhibitor with potential antineoplastic activity. Unlike other Src kinase inhibitors which bind to the ATP-binding site, Src kinase inhibitor KX2-391 specifically binds to the peptide substrate binding site of Src kinase; inhibition of kinase activity may result in the inhibition of primary tumor growth and the suppression of metastasis. Src tyrosine kinases are upregulated in many tumor cells and play important roles in tumor cell proliferation and metastasis. Uses: Enzyme inhibitors. Group: Pharmaceutical. CAS No. 897016-82-9. Pack Sizes: 50 mg. Product ID: B2693-460303. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| KY-226 | KY-226 is a protein tyrosine phosphatase 1B (PTP1B) inhibitor that protects neurons from cerebral ischemic injury. It significantly reduced plasma glucose, triglyceride, and A1c levels without weight gain in db/db mice. Uses: Enzyme inhibitors. Group: Pharmaceutical. CAS No. 1621673-53-7. Pack Sizes: 25 mg. Product ID: B2693-010435. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Kynurenine Impurities | Kynurenine Impurities represent vital components in the intricate examination of the kynurenine pathway's modulation, intricately connected to neurodegenerative afflictions like Alzheimer's and Parkinson's. These impurities unravel complex pathophysiological mechanisms and aid in devising therapeutic strategies targeting disruptions in tryptophan metabolism, thereby enhancing the understanding of related disorders. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-685,458 | L-685,458 is a potent and selective inhibitor of γ-secretase (IC50 = 17 nM) that shows 50-fold selectivity over a variety of aspartyl proteases. It also inhibits Aβ40 and Aβ42 peptides (in human neuroblastoma cells: IC50 = 48 and 67 nM respectively). Uses: Gamma secretase inhibitors and modulators. Group: Pharmaceutical. CAS No. 292632-98-5. Pack Sizes: 25 mg. Product ID: B2693-286396. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-778123 HCl | L-778123 is an inhibitor of FPTase and GGPTase-I, which was developed in part because it can completely inhibit Ki-Ras prenylation. Group: Pharmaceutical. CAS No. 253863-00-2. Pack Sizes: 50 mg. Product ID: B0084-176694. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Labd-13(E)-ene-8α,15-diol | Labd-13-ene-8,15-diol is a natural diterpenoid found in the fruits of Zizyphus jujuba. Group: Pharmaceutical. CAS No. 10267-31-9. Pack Sizes: 1 mg. Product ID: NP1274. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Labetalol-1-carboxylic Acid Methyl Ester | An impurity of Labetalol, a beta blocker used to treat high blood pressure. Group: Pharmaceutical. CAS No. 802620-01-5. Pack Sizes: 100 mg. Product ID: B2694-009631. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Labetalol Impurities | Labetalol Impurities are critical in the biomedical industry for ensuring the purity and efficacy of labetalol, a medication used to manage hypertension and angina. The identification and quantification of these impurities aid in drug formulation, enhancing therapeutic outcomes and ensuring patient safety through rigorous quality control processes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Labetalol Impurity A | Labetalol Impurity A is an impurity of Labetalol, a medication used for the treatment of high blood pressure, and also for long term management of angina. Group: Pharmaceutical. CAS No. 1391051-99-2. Pack Sizes: 2 g. Product ID: B1275-473550. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Labetalol Impurity C | an intermediate of Labetalol Impurity. Group: Pharmaceutical. CAS No. 30566-92-8. Pack Sizes: 25 mg. Product ID: B2694-065637. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lacidipine | Lacidipine (Lacipil, Motens) is a L-type calcium channel blocker. Lacidipine (Lacipil, Motens) works by relaxing and opening up the blood vessels. Group: Pharmaceutical. CAS No. 103890-78-4. Pack Sizes: 5 g. Product ID: B2693-053442. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lacidipine Impurities | Lacidipine Impurities, crucial artifacts in pharmaceutical evaluations, manifest as influential byproducts or remnants from Lacidipine synthesis. Rigorous analysis is paramount for ensuring treatment purity and safety, anchoring drug efficacy and reducing adverse effects, thereby safeguarding therapeutic standards in antihypertensive interventions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lacosamide EP Impurity I | One of the impurities of Lacosamide. Lacosamide is a medication used for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. Group: Pharmaceutical. CAS No. 2295925-90-3. Pack Sizes: 50 mg. Product ID: B2694-377353. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lacosamide Impurities | Lacosamide Impurities, serving as essential analytical benchmarks, are foundational in the pharmaceutical realm to ensure the purity and efficacy of lacosamide, a vital therapeutic agent for partial-onset epileptic seizures. These impurities enable stringent quality assurance, enhancing the safety and clinical reliability of the drug while optimizing performance metrics. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lactisole sodium | Lactisole is a sweet taste receptor antagonist that suppresses perception of sweetness in humans. It blocks a heterodimeric receptor comprised of T1R2+T1R3, which detects sweet-tasting compounds. Group: Pharmaceutical. CAS No. 150436-68-3. Pack Sizes: 50 g. Product ID: B1370-199888. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lactitol Impurities | Lactitol Impurities are critical in quality control and pharmaceutical synthesis for developing lactitol-based therapeutics. Although not directly used to treat specific diseases, their identification and quantification ensure the safety and efficacy of pharmaceuticals targeting conditions such as constipation and hepatic encephalopathy. These impurities are fundamental in research and regulatory compliance. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lactoferrin | Lactoferrin is a multifunctional globular glycoprotein of the transferrin family. Uses: lactoferrin is a multifunctional glycoprotein that plays a crucial role in various biological processes, including antimicrobial activity, immune modulation, and iron homeostasis. in recent years, research has shown that lactoferrin holds great potential in the field of drug discovery and development due to its diverse range of biological activities and therapeutic properties.
saliva, tea. Group: Pharmaceutical. CAS No. 146897-68-9. Pack Sizes: 10 g. Product ID: BAT-010208. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lactonic Sophorolipid | Lactonic sophorolipid is a natural antimicrobial surfactant for oral hygiene. Lactonic sophorolipid, a potential anticancer agent, induces apoptosis in human HepG2 cells through the caspase-3 pathway. Uses: Widely used in oilfield field, environmental remediation field, agriculture, animal husbandry and aquaculture fields, daily chemicals, cleaning, personal care: it can replace chemical surfactants, with excellent surface performance, safety, biodegradability, strong detergency, low foam type and easy to rinse. Group: Pharmaceutical. CAS No. 148409-20-5. Pack Sizes: 5 g. Product ID: B1370-003897. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lacto-N-neohexaose | Lacto-N-neohexaose is a cutting-edge compound with remarkable anti-inflammatory powers, aiding in the research of autoimmune disorders, most notably rheumatoid arthritis. Group: Pharmaceutical. CAS No. 64003-52-7. Pack Sizes: 5 mg. Product ID: B1370-003254. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lacto-N-triose II | Lacto-N-triose II is a profoundly sophisticated compound, vividly contributing to studying an assortment of afflictions, notably cancer, autoimmune disorders and neurological ailments. It has the unparalleled aptitude for pinpointing discrete cells and catalyzing targeted pharmaceutical transportation. Group: Pharmaceutical. CAS No. 75645-27-1. Pack Sizes: 10 mg. Product ID: B1370-003263. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lactosylsphingosine | Lactosylsphingosine, a sphingolipid, is a vital biomarker characterizing diverse lysosomal storage disorders such as Niemann-Pick disease and Gaucher disease due to its accumulation within the tissues and blood of affected people. Detection through blood examination or imaging studies makes identification possible. Therapy options include substrate reduction and enzyme replacement therapy. Furthermore, tracking variations in lactosylsphingosine may be employed to monitor therapy response and trace disease advancement, imparting substantial clinical value in disease management. Group: Pharmaceutical. CAS No. 109785-20-8. Pack Sizes: 1 mg. Product ID: B2705-003271. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lactulose | Lactulose, a disaccharide composed of galactose and fructose, is a stimulator of health-promoting bacterium growth in the gastrointestinal tract, used to treat chronic constipation and hepatic encephalopathy. Uses: Gastrointestinal agents. Group: Pharmaceutical. CAS No. 4618-18-2. Pack Sizes: 500 g. Product ID: B1370-003272. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lafutidine Impurities | Lafutidine Impurities undergo comprehensive scrutiny, ensuring the safety and therapeutic efficacy of Lafutidine, a powerful H2-receptor antagonist utilized in gastric ulcer and GERD management. This rigorous analysis, crucial for pharmaceutical compliance, helps sustain the drug's therapeutic consistency and maximizes its clinical benefits, affirming its role in medical treatments. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (+)-L-Alliin | (+)-L-Alliin is a precursor to Allicin, a cysteine sulfoxide constituent of garlic. Allicin exhibits antibacterial and antioxidant activity. Group: Pharmaceutical. CAS No. 556-27-4. Pack Sizes: 100 mg. Product ID: B2703-465520. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-α-Aspartyl-D-phenylalanine methyl ester | L-α-Aspartyl-D-phenylalanine methyl ester, a dipeptide compound, bears promise in the biomedical sector for its potential inhibitory impact on angiotensin converting enzyme (ACE), thus potentially reducing blood pressure levels. It has also shown potential in the treatment of hypertensive, cardiac failure, and other cardiovascular conditions. The study of its properties continues to generate interest and attention from academia and the scientific community. Group: Pharmaceutical. CAS No. 22839-65-2. Pack Sizes: 50 mg. Product ID: B2699-116576. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-α-Methyltyrosine | L-α-Methyltyrosine is a tyrosine hydroxylase inhibitor. It is used to control the symptoms of excessive sympathetic stimulation in patients with pheochromocytoma. It reduces the elevated levels of catecholamines associated with pheochromocytoma, thus preventing hypertension. It significantly inhibits COX-2 activity and has anti-inflammatory and anti-ulcer effects. Uses: L-α-methyltyrosine is used to control the symptoms of excessive sympathetic stimulation in patients with pheochromocytoma. Group: Pharmaceutical. CAS No. 672-87-7. Pack Sizes: 5 g. Product ID: BAT-008124. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-α-phosphatidylcholine (soybean, hydrogenated) | L-α-phosphatidylcholine (soybean, hydrogenated) is a saturated phospholipid used in liposomal drug delivery formulations. It is also known to increase the solubility and bioavailability of hydrophobic drugs. Group: Pharmaceutical. CAS No. 97281-48-6. Pack Sizes: 5 g. Product ID: B1370-011110. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Laminin (925-933) | Laminin β-1 Chain (925-933) (human, mouse) is a peptide derivative from residues 925-933 of the laminin B1 chain. It binds to the laminin receptor. Group: Pharmaceutical. CAS No. 110590-60-8. Pack Sizes: 5 mg. Product ID: BAT-006102. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lamivudine | Lamivudine is a potent nucleoside analog reverse transcriptase inhibitor, used for treatment of chronic HBV and HIV/AIDS. Group: Pharmaceutical. CAS No. 134678-17-4. Pack Sizes: 50 g. Product ID: BBF-04130. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lamivudine Impurities | Lamivudine Impurities, essential in the realm of antiretroviral pharmacology, underpin the development and stringent quality assessment of HIV and Hepatitis B therapeutics. These impurities play a crucial role in verifying the safety, potency, and uniformity of lamivudine, thus facilitating drug formulation and ensuring adherence to regulatory standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lamivudine Impurity G | AmetaboliteofLamivudine, anantiviralthatinhibitsHIV-reversetranscriptase. Group: Pharmaceutical. CAS No. 160552-55-6. Pack Sizes: 50 mg. Product ID: B2694-473581. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lanabecestat | Lanabecestat, also referred to AZD3293, is an orally active and highly permeable potent inhibitor of human β-secretase 1 in clinical development for the treatment of Alzheimer disease with a Ki of 0.4 nM. Group: Pharmaceutical. CAS No. 1383982-64-6. Pack Sizes: 5 mg. Product ID: B2693-007728. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Landiolol Impurities | Landiolol Impurities are integral to the meticulous quality assurance and progressive development of beta-blocker pharmaceuticals. These impurities critically ensure Landiolol's safety and therapeutic efficacy, a cardio-selective agent targeting arrhythmias and hypertension, through the identification and quantification of contaminants within the intricate synthesis and formulation stages. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lanifibranor | Lanifibranor is a peroxisome proliferator-activated receptors (PPAR) agonist. Group: Pharmaceutical. CAS No. 927961-18-0. Pack Sizes: 25 mg. Product ID: B0084-260291. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lanosterol | Lanosterol is a sterol cholesterol precursor found in Mushroom Inonotus obliquus. Group: Pharmaceutical. CAS No. 79-63-0. Pack Sizes: 50 mg. Product ID: BBF-04112. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lanreotide | Laromustine is a sulfonyl hydrazine prodrug with antineoplastic activity. Laromustine releases the DNA chloroethylating agent 90CE after entering the blood stream; 90CE chloroethylates alkylates the 06 position of guanine, resulting in DNA crosslinking, strand breaks, chromosomal aberrations, and disruption of DNA synthesis. Intracellular metabolism of this agent also releases methyl isocyanate which inhibits 06-alkyl-guanine transferase, an enzyme involved with DNA repair. Group: Pharmaceutical. CAS No. 108736-35-2. Pack Sizes: 25 mg. Product ID: BAT-010202. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lanreotide Impurities | Lanreotide Impurities are instrumental in the quality control processes of lanreotide, aiding in the management of acromegaly and neuroendocrine tumor symptoms. These components are crucial for evaluating the drug's purity, stability, and safety parameters, ensuring adherence to rigorous pharmaceutical standards for therapeutic effectiveness. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lansoprazole EP Impurity B | An impurity of lansoprazole, a proton pump inhibitor (PPI) used to treat the symptoms of gastroesophageal reflux disease (GERD). Group: Pharmaceutical. CAS No. 131926-99-3. Pack Sizes: 20 mg. Product ID: B0064-302135. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lansoprazole Impurities | Lansoprazole Impurities, integral to biomedical spheres, are crucial for assessing both the purity and stability of lansoprazole, a therapeutic agent for GERD, peptic ulcers, and Zollinger-Ellison syndrome. Through their presence, enhanced formulations are devised, and rigorous quality control in pharmaceutical production is meticulously upheld. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lansoprazole N-oxide | An impurity of lansoprazole, a proton pump inhibitor (PPI) used to treat the symptoms of gastroesophageal reflux disease (GERD). Group: Pharmaceutical. CAS No. 213476-12-1. Pack Sizes: 10 mg. Product ID: B0064-262398. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lansoprazole Related Compound 3 | Lansoprazole impurity. Group: Pharmaceutical. CAS No. 1083100-27-9. Pack Sizes: 50 mg. Product ID: B0064-462143. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lansoprazole Thioxo Impurity | Lansoprazole impurity. Group: Pharmaceutical. CAS No. 1246819-06-6. Pack Sizes: 5 mg. Product ID: B0064-473608. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lanthionine Impurities | Lanthionine Impurities, essential in drug substance refinement, are critical for ensuring the purity of lanthionine, fundamentally linked to antimicrobial peptides like nisin. By optimizing antibiotic formulations, they support targeted therapeutic interventions against resistant bacterial strains, thus playing a pivotal role in combating infectious diseases and enhancing drug safety profiles. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lapachol Impurities | Lapachol Impurities are crucial in the biomedical industry for their role in assessing drug formulation purity and stability. These impurities help understand the pharmacokinetic profiles of drugs derived from lapachol, which are investigated for potential anticancer, antimalarial, and antimicrobial therapeutic applications. They ensure the safety and efficacy of lapachol-related pharmaceuticals. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lapatinib | Lapatinib, used in the form of Lapatinib Ditosylate, is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM, respectively. Uses: Antineoplastic agents; protein kinase inhibitors. Group: Pharmaceutical. CAS No. 231277-92-2. Pack Sizes: 1 g. Product ID: NP3214. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lapatinib Ditosylate | Lapatinib is a synthetic, orally-active quinazoline with potential antineoplastic activity. Lapatinib reversibly blocks phosphorylation of the epidermal growth factor receptor (EGFR), ErbB2, and the Erk-1 and-2 and AKT kinases; it also inhibits cyclin D protein levels in human tumor cell lines and xenografts. EGFR and ErbB2 have been implicated in the growth of various tumor types. Uses: Antineoplastic agents. Group: Pharmaceutical. CAS No. 388082-77-7. Pack Sizes: 1 g. Product ID: B0084-067756. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lapatinib Hydroxylamine | a complex used in human metabolism of lapatinib which is a dual kinase inhibitor. Group: Pharmaceutical. CAS No. 1360431-86-2. Pack Sizes: 10 mg. Product ID: B2694-473628. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lapatinib Impurities | Lapatinib Impurities are crucial analytical reference materials used in the biomedical industry to ensure the safety, potency, and efficacy of Lapatinib, a tyrosine kinase inhibitor. Lapatinib is primarily prescribed for treating HER2-positive breast cancer. These impurities aid in the comprehensive understanding of the drug's pharmacokinetics and stability profile. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lappaconitine | Lappaconitine, extracted form the roots of Aconitum carmichaeli Debx, has neurotoxic, cardiotoxic and strong analgesic activities that does not involve the opioid receptor, and further suggest that the central nervous system may be involved in the action. Group: Pharmaceutical. CAS No. 32854-75-4. Pack Sizes: 100 mg. Product ID: B0005-465422. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Larazotide acetate | Larazotide acetate is a tight junction regulator and reverses leaky junctions to their normally closed state. Group: Pharmaceutical. CAS No. 881851-50-9. Pack Sizes: 50 mg. Product ID: BAT-006238. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Arginine α-ketoglutarate | L-Arginine α-ketoglutarate is a salt form of arginine, which is the nitrogen donor for synthesis of nitric oxide, a potent vasodilator that is deficient during times of sickle cell crisis. Protein supplement in health care products. Uses: Ingredient of health care products. Group: Pharmaceutical. CAS No. 16856-18-1. Pack Sizes: 100 g. Product ID: B0350-340579. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Laropiprant | a drug used in combination with niacin to reduce blood cholesterol (LDL and VLDL) that is no longer sold. Uses: A potent, selective dp1 receptor antagonist. Group: Pharmaceutical. CAS No. 571170-77-9. Pack Sizes: 50 mg. Product ID: B0084-474242. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Laropiprant Impurities | Laropiprant Impurities serve as essential components in pharmaceutical development, vital for ensuring the quality and purity of laropiprant-centric medications targeting hypercholesterolemia and cardiovascular ailments. They facilitate comprehension of metabolic pathways, refine formulation techniques, and improve drug safety and efficacy within clinical contexts, providing significant contributions to therapeutic advancements. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Larotaxel | Larotaxel is a semi-synthetic derivative of the taxane 10-deacetylbaccatin III with potential antineoplastic activities. Larotaxel binds to tubulin, promoting microtubule assembly and stabilization and preventing microtubule depolymerization, thereby inhibiting cell proliferation. As it represents poor substrate for P-glycoprotein-related drug resistance mechanisms, this agent may be useful for treating multi-drug resistant tumors. Larotaxel penetrates the blood brain barrier. Group: Pharmaceutical. CAS No. 156294-36-9. Pack Sizes: 50 mg. Product ID: B2693-244933. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lasalocid Impurities | Lasalocid impurities, crucial in pharmaceutical quality control, are employed to ensure the purity of lasalocid formulations. These compounds are significant in the development and manufacture of veterinary antibiotics and anticoccidial agents, primarily targeting poultry diseases. Understanding these impurities aids in refining the synthesis and safety of lasalocid-based products. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lasofoxifene | Lasofoxifene (INN) (proposed tradename Fablyn) is a non-steroidal selective estrogen receptor modulator (SERM) which is under development by Pfizer for the prevention and treatment of osteoporosis and for the treatment of vaginal atrophy, and the result of an exclusive research collaboration with Ligand Pharmaceuticals (LGND). In September 2005, Pfizer received a non-approvable letter from the U.S. Food and Drug Administration regarding lasofoxifene ( Oporia), a selective estrogen receptor modulator for the prevention of osteoporosis. Lasofoxifene was approved in the EU under the Fablyn by the EMEA in March 2009. Lasofoxifene is a desmethyl dihydro analog of nafoxidine. Group: Pharmaceutical. CAS No. 180916-16-9. Pack Sizes: 100 mg. Product ID: B2693-465309. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lasofoxifene Impurities | Lasofoxifene Impurities, critical to biomedical examination, fortify the validation of Lasofoxifene's efficacy as a selective estrogen receptor modulator. By decoding contamination spectra and stability paradigms, they enhance osteoporosis and breast cancer management, while augmenting drug formulation frameworks and regulatory compliance, thereby anchoring therapeutic advancements and ensuring rigorous safety protocols. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lasofoxifene tartrate | Lasofoxifene tartrate is the tartrate salt form of Lasofoxifene. Lasofoxifene is a third-generation selective estrogen receptor modulators (SERMs). Group: Pharmaceutical. CAS No. 190791-29-8. Pack Sizes: 100 mg. Product ID: B0084-086542. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Aspartic acid di-tert-butyl ester hydrochloride | L-Aspartic acid di-tert-butyl ester hydrochloride. Group: Pharmaceutical. CAS No. 1791-13-5. Pack Sizes: 500 g. Product ID: BAT-004225. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Latamoxef Impurities | Latamoxef Impurities are critical in pharmaceutical research, primarily to ensure drug purity and safety standards. These impurities, derivatives or by-products of Latamoxef, a wide-spectrum antibiotic, are essential for analyzing and quantifying Latamoxef in formulations, thereby enhancing the treatment of bacterial infections. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Latanoprost | Latanoprost is the isopropyl ester of 17-phenyl-13,14-dihydro prostaglandin F2α (17-phenyl-13,14-dihydro PGF2α). It is a prodrug form of the free acid, which is a potent agonist of the FP receptor in the eye. Latanoprost reduces intraocular pressure in glaucoma patients with few side effects. The EC50 value of latanoprost (tested as the free acid) for FP receptors is 3.6 nM. Group: Pharmaceutical. CAS No. 130209-82-4. Pack Sizes: 50 mg. Product ID: B0084-056938. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Latanoprost Acid | A metabolite of Latanoprost. Group: Pharmaceutical. CAS No. 41639-83-2. Pack Sizes: 50 mg. Product ID: B1289-092108. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.